Since the signaling pathways for these ligand-bound GPCRs involve PC-PLC activation [26-28], we hypothesize that migraine and its comorbidities share a common pathway of receptor-mediated, lipid second-messengers that are regulated by PLC activation. The gene discussed is HSPG2; the disease is migraine disorder.